Neurona Therapeutics
Financing Rounds
- Series B
- Series C
Round Led by Symbiosis
Round Led by Symbiosis
Neurona has built a robust regenerative platform based on a novel neural cell lineage developed by the company’s scientific founders, and is developing off-the-shelf, allogeneic neuronal, glial, and gene edited cell therapy candidates that provide long-term integration and repair of dysfunctional neural networks for multiple neurological disorders. Neurona’s cell therapies have single-dose curative potential.
